Snowflake Inc.833445109US833445109807/02/2025Election of Class II Directors for terms expiring in 2028: Kelly A. KramerDIRECTOR ELECTIONSISSUER386533.0000000FOR386533.000000FORS000002337Snowflake Inc.833445109US833445109807/02/2025Election of Class II Directors for terms expiring in 2028: Frank SlootmanDIRECTOR ELECTIONSISSUER386533.0000000FOR386533.000000FORS000002337Snowflake Inc.833445109US833445109807/02/2025Election of Class II Directors for terms expiring in 2028: Michael L. SpeiserDIRECTOR ELECTIONSISSUER386533.0000000FOR386533.000000FORS000002337Snowflake Inc.833445109US833445109807/02/2025To approve, on a non-binding advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER386533.0000000AGAINST386533.000000AGAINSTS000002337Snowflake Inc.833445109US833445109807/02/2025To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending January 31, 2026.AUDIT-RELATEDISSUER386533.0000000FOR386533.000000FORS000002337Snowflake Inc.833445109US833445109807/02/2025To approve an amendment to our Amended and Restated Certificate of Incorporation to declassify our Board of Directors.SHAREHOLDER RIGHTS AND DEFENSESISSUER386533.0000000FOR386533.000000FORS000002337Snowflake Inc.833445109US833445109807/02/2025To approve an amendment to our Amended and Restated Certificate of Incorporation to remove references to Class B common stock and rename Class A common stock to common stock.CAPITAL STRUCTURECORPORATE GOVERNANCEISSUER386533.0000000FOR386533.000000FORS000002337Roivant Sciences Ltd.G76279101BMG76279101709/10/2025To elect the Board of Directors' three nominees for Class I Director to serve for a three-year term: Matthew GlineDIRECTOR ELECTIONSISSUER1084816.0000000FOR1084816.000000FORS000002337Roivant Sciences Ltd.G76279101BMG76279101709/10/2025To elect the Board of Directors' three nominees for Class I Director to serve for a three-year term: Keith ManchesterDIRECTOR ELECTIONSISSUER1084816.0000000FOR1084816.000000FORS000002337Roivant Sciences Ltd.G76279101BMG76279101709/10/2025To elect the Board of Directors' three nominees for Class I Director to serve for a three-year term: Melissa EpperlyDIRECTOR ELECTIONSISSUER1084816.0000000FOR1084816.000000FORS000002337Roivant Sciences Ltd.G76279101BMG76279101709/10/2025To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as Roivant's independent registered public accounting firm for Roivant's fiscal year ending March 31, 2026, to appoint Ernst & Young LLP as auditor for statutory purposes under the Bermuda Companies Act 1981, as amended, for Roivant's fiscal year ending March 31, 2026, and to authorize the Board of Directors, through the Audit Committee, to set the remuneration for Ernst & Young LLP as Roivant's auditor for Roivant's fiscal year ending March 31, 2026.AUDIT-RELATEDISSUER1084816.0000000FOR1084816.000000FORS000002337Roivant Sciences Ltd.G76279101BMG76279101709/10/2025To cast a non-binding, advisory vote to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1084816.0000000FOR1084816.000000FORS000002337Tesla, Inc.88160R101US88160R101411/06/2025A Tesla proposal to elect three Class III directors to serve for a term of three years, or until their respective successors are duly elected and qualified: Ira EhrenpreisDIRECTOR ELECTIONSISSUER275414.0000000FOR275414.000000FORS000002337Tesla, Inc.88160R101US88160R101411/06/2025A Tesla proposal to elect three Class III directors to serve for a term of three years, or until their respective successors are duly elected and qualified: Joe GebbiaDIRECTOR ELECTIONSISSUER275414.0000000FOR275414.000000FORS000002337Tesla, Inc.88160R101US88160R101411/06/2025A Tesla proposal to elect three Class III directors to serve for a term of three years, or until their respective successors are duly elected and qualified: Kathleen Wilson-ThompsonDIRECTOR ELECTIONSISSUER275414.0000000FOR275414.000000FORS000002337Tesla, Inc.88160R101US88160R101411/06/2025A Tesla proposal for a non-binding advisory vote approving 2024 executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER275414.0000000FOR275414.000000FORS000002337Tesla, Inc.88160R101US88160R101411/06/2025A Tesla proposal for approval of the A&R 2019 Equity Incentive Plan.COMPENSATIONISSUER275414.0000000FOR275414.000000FORS000002337Tesla, Inc.88160R101US88160R101411/06/2025A Tesla proposal for approval of the 2025 CEO Performance Award.COMPENSATIONISSUER275414.0000000FOR275414.000000FORS000002337Tesla, Inc.88160R101US88160R101411/06/2025A Tesla proposal for the ratification of the appointment of PricewaterhouseCoopers LLP as Tesla's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER275414.0000000FOR275414.000000FORS000002337Tesla, Inc.88160R101US88160R101411/06/2025A Tesla proposal for adoption of amendments to certificate of formation and bylaws to eliminate applicable supermajority voting requirements.CORPORATE GOVERNANCEISSUER275414.0000000FOR275414.000000NONES000002337Tesla, Inc.88160R101US88160R101411/06/2025A shareholder proposal regarding Board authorization of an investment in xAl.CORPORATE GOVERNANCESECURITY HOLDER275414.0000000FOR275414.000000NONES000002337Tesla, Inc.88160R101US88160R101411/06/2025A shareholder proposal regarding adopting targets and reporting on metrics to assess the feasibility of integrating sustainability metrics into senior executive compensation plans.COMPENSATIONCORPORATE GOVERNANCEENVIRONMENT OR CLIMATEHUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCEDIVERSITY, EQUITY, AND INCLUSIONOTHER SOCIAL ISSUESSECURITY HOLDER275414.0000000AGAINST275414.000000FORS000002337Tesla, Inc.88160R101US88160R101411/06/2025A shareholder proposal requesting a child labor audit.HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCESECURITY HOLDER275414.0000000AGAINST275414.000000FORS000002337Tesla, Inc.88160R101US88160R101411/06/2025A shareholder proposal to amend the bylaws to repeal 3% derivative suit ownership threshold.CORPORATE GOVERNANCESECURITY HOLDER275414.0000000FOR275414.000000AGAINSTS000002337Tesla, Inc.88160R101US88160R101411/06/2025A shareholder proposal to amend Article X of the bylaws.CORPORATE GOVERNANCESECURITY HOLDER275414.0000000FOR275414.000000AGAINSTS000002337Tesla, Inc.88160R101US88160R101411/06/2025A shareholder proposal to elect each director annually.SHAREHOLDER RIGHTS AND DEFENSESSECURITY HOLDER275414.0000000FOR275414.000000AGAINSTS000002337Tesla, Inc.88160R101US88160R101411/06/2025A shareholder proposal regarding proposal that won 54% support at 2024 Tesla annual meeting.CORPORATE GOVERNANCESECURITY HOLDER275414.0000000FOR275414.000000AGAINSTS000002337Tesla, Inc.88160R101US88160R101411/06/2025A shareholder proposal to seek shareholder approval before adopting an amendment to the bylaws pursuant to Section 21.373 of the TBOC.CORPORATE GOVERNANCESECURITY HOLDER275414.0000000FOR275414.000000AGAINSTS000002337Affirm Holdings, Inc.00827B106US00827B106112/15/2025To elect the three Class II nominees for director named in the accompanying proxy statement to hold office until the 2028 Annual Meeting and until their successors have been duly elected and qualified or until such director's earlier death, resignation or removal: Richard GalantiDIRECTOR ELECTIONSISSUER1372543.0000000FOR1372543.000000FORS000002337Affirm Holdings, Inc.00827B106US00827B106112/15/2025To elect the three Class II nominees for director named in the accompanying proxy statement to hold office until the 2028 Annual Meeting and until their successors have been duly elected and qualified or until such director's earlier death, resignation or removal: Christa S. QuarlesDIRECTOR ELECTIONSISSUER1372543.0000000FOR1372543.000000FORS000002337Affirm Holdings, Inc.00827B106US00827B106112/15/2025To elect the three Class II nominees for director named in the accompanying proxy statement to hold office until the 2028 Annual Meeting and until their successors have been duly elected and qualified or until such director's earlier death, resignation or removal: Manuel SanchezDIRECTOR ELECTIONSISSUER1372543.0000000FOR1372543.000000FORS000002337Affirm Holdings, Inc.00827B106US00827B106112/15/2025To ratify the Audit Committee's selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2026.AUDIT-RELATEDISSUER1372543.0000000FOR1372543.000000FORS000002337Affirm Holdings, Inc.00827B106US00827B106112/15/2025To approve, on a non-binding advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1372543.0000000FOR1372543.000000FORS000002337Bitmine Immersion Technologies, Inc.09175A206US09175A206901/15/2026ELECTIONS OF DIRECTORS: Thomas LeeDIRECTOR ELECTIONSISSUER751135.0000000FOR751135.000000FORS000002337Bitmine Immersion Technologies, Inc.09175A206US09175A206901/15/2026ELECTIONS OF DIRECTORS: Chi TsangDIRECTOR ELECTIONSISSUER751135.0000000FOR751135.000000FORS000002337Bitmine Immersion Technologies, Inc.09175A206US09175A206901/15/2026ELECTIONS OF DIRECTORS: Michael MaloneyDIRECTOR ELECTIONSISSUER751135.0000000FOR751135.000000FORS000002337Bitmine Immersion Technologies, Inc.09175A206US09175A206901/15/2026ELECTIONS OF DIRECTORS: Lori LoveDIRECTOR ELECTIONSISSUER751135.0000000FOR751135.000000FORS000002337Bitmine Immersion Technologies, Inc.09175A206US09175A206901/15/2026ELECTIONS OF DIRECTORS: David SharbuttDIRECTOR ELECTIONSISSUER751135.0000000FOR751135.000000FORS000002337Bitmine Immersion Technologies, Inc.09175A206US09175A206901/15/2026ELECTIONS OF DIRECTORS: Jason EdgeworthDIRECTOR ELECTIONSISSUER751135.0000000FOR751135.000000FORS000002337Bitmine Immersion Technologies, Inc.09175A206US09175A206901/15/2026ELECTIONS OF DIRECTORS: Olivia HoweDIRECTOR ELECTIONSISSUER751135.0000000FOR751135.000000FORS000002337Bitmine Immersion Technologies, Inc.09175A206US09175A206901/15/2026ELECTIONS OF DIRECTORS: Robert SechanDIRECTOR ELECTIONSISSUER751135.0000000FOR751135.000000FORS000002337Bitmine Immersion Technologies, Inc.09175A206US09175A206901/15/2026To approve the charter amendment to increase the number of authorized shares of Common Stock.CAPITAL STRUCTUREISSUER751135.0000000FOR751135.000000FORS000002337Bitmine Immersion Technologies, Inc.09175A206US09175A206901/15/2026To approve the 2025 Omnibus Incentive Plan.COMPENSATIONISSUER751135.0000000FOR751135.000000FORS000002337Bitmine Immersion Technologies, Inc.09175A206US09175A206901/15/2026To approve, on a non-binding advisory basis, the special, performance-based compensation arrangement for the executive chairman.COMPENSATIONISSUER751135.0000000FOR751135.000000FORS000002337agilon health, inc.00857U206US00857U206903/17/2026Approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company's common stock by a ratio of one-for-five to one-for-twenty-five, with the exact ratio to be set within this range by the Board of Directors in its sole discretion (without reducing the authorized number of shares of the Company's common stock) (the "Amendment Proposal"); andCAPITAL STRUCTUREISSUER8046130.0000000FOR8046130.000000FORS000002337agilon health, inc.00857U206US00857U206903/17/2026Approval of the adjournment of the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the Amendment Proposal.CORPORATE GOVERNANCEISSUER8046130.0000000FOR8046130.000000FORS000002337QXO, Inc.82846H405US82846H405605/05/2026Election of Directors: Brad JacobsDIRECTOR ELECTIONSISSUER3739997.0000000FOR3739997.000000FORS000002337QXO, Inc.82846H405US82846H405605/05/2026Election of Directors: Jason AikenDIRECTOR ELECTIONSISSUER3739997.0000000FOR3739997.000000FORS000002337QXO, Inc.82846H405US82846H405605/05/2026Election of Directors: Marlene ColucciDIRECTOR ELECTIONSISSUER3739997.0000000FOR3739997.000000FORS000002337QXO, Inc.82846H405US82846H405605/05/2026Election of Directors: Mario HarikDIRECTOR ELECTIONSISSUER3739997.0000000FOR3739997.000000FORS000002337QXO, Inc.82846H405US82846H405605/05/2026Election of Directors: Mary KisselDIRECTOR ELECTIONSISSUER3739997.0000000FOR3739997.000000FORS000002337QXO, Inc.82846H405US82846H405605/05/2026Election of Directors: Jared KushnerDIRECTOR ELECTIONSISSUER3739997.0000000FOR3739997.000000FORS000002337QXO, Inc.82846H405US82846H405605/05/2026Election of Directors: Allison LandryDIRECTOR ELECTIONSISSUER3739997.0000000FOR3739997.000000FORS000002337QXO, Inc.82846H405US82846H405605/05/2026Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal year 2026.AUDIT-RELATEDISSUER3739997.0000000FOR3739997.000000FORS000002337QXO, Inc.82846H405US82846H405605/05/2026Advisory vote to approve executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER3739997.0000000FOR3739997.000000FORS000002337Aurora Innovation, Inc.051774107US051774107205/21/2026Election of Directors: Gloria BoylandDIRECTOR ELECTIONSISSUER9733307.0000000FOR9733307.000000FORS000002337Aurora Innovation, Inc.051774107US051774107205/21/2026Election of Directors: Michelangelo VolpiDIRECTOR ELECTIONSISSUER9733307.0000000FOR9733307.000000FORS000002337Aurora Innovation, Inc.051774107US051774107205/21/2026Election of Directors: Lara CaimiDIRECTOR ELECTIONSISSUER9733307.0000000FOR9733307.000000FORS000002337Aurora Innovation, Inc.051774107US051774107205/21/2026Approval, on an advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER9733307.0000000FOR9733307.000000FORS000002337Aurora Innovation, Inc.051774107US051774107205/21/2026Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for fiscal year 2026.AUDIT-RELATEDISSUER9733307.0000000FOR9733307.000000FORS000002337XOMA Royalty Corporation98419J206US98419J206905/21/2026Election of Director Nominees: To be elected for terms expiring in 2027: Owen HughesDIRECTOR ELECTIONSISSUER252069.0000000FOR252069.000000FORS000002337XOMA Royalty Corporation98419J206US98419J206905/21/2026Election of Director Nominees: To be elected for terms expiring in 2027: Jack L. WyszomierskiDIRECTOR ELECTIONSISSUER252069.0000000FOR252069.000000FORS000002337XOMA Royalty Corporation98419J206US98419J206905/21/2026Election of Director Nominees: To be elected for terms expiring in 2027: Heather L. FranklinDIRECTOR ELECTIONSISSUER252069.0000000FOR252069.000000FORS000002337XOMA Royalty Corporation98419J206US98419J206905/21/2026Election of Director Nominees: To be elected for terms expiring in 2027: Natasha HerndayDIRECTOR ELECTIONSISSUER252069.0000000FOR252069.000000FORS000002337XOMA Royalty Corporation98419J206US98419J206905/21/2026Election of Director Nominees: To be elected for terms expiring in 2027: Barbara KosaczDIRECTOR ELECTIONSISSUER252069.0000000FOR252069.000000FORS000002337XOMA Royalty Corporation98419J206US98419J206905/21/2026Election of Director Nominees: To be elected for terms expiring in 2027: Joseph M. LimberDIRECTOR ELECTIONSISSUER252069.0000000FOR252069.000000FORS000002337XOMA Royalty Corporation98419J206US98419J206905/21/2026Election of Director Nominees: To be elected for terms expiring in 2027: Matthew D. PerryDIRECTOR ELECTIONSISSUER252069.0000000FOR252069.000000FORS000002337XOMA Royalty Corporation98419J206US98419J206905/21/2026Ratification of the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER252069.0000000FOR252069.000000FORS000002337XOMA Royalty Corporation98419J206US98419J206905/21/2026Approval of an amendment and restatement of the 2010 Long Term Incentive and Stock Award Plan.COMPENSATIONISSUER252069.0000000FOR252069.000000FORS000002337XOMA Royalty Corporation98419J206US98419J206905/21/2026Approval of the 2026 Employee Stock Purchase Plan.COMPENSATIONISSUER252069.0000000FOR252069.000000FORS000002337XOMA Royalty Corporation98419J206US98419J206905/21/2026Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER252069.0000000FOR252069.000000FORS000002337Arbutus Biopharma Corporation03879J100CA03879J100305/26/2026To elect five (5) director nominees named in the Proxy Statement/Circular, each to serve until the 2027 Annual General and Special Meeting of Shareholders or until his or her qualified successor has been duly elected or appointed: Lindsay Androski, JD, MBA, CFADIRECTOR ELECTIONSISSUER3833797.0000000FOR3833797.000000FORS000002337Arbutus Biopharma Corporation03879J100CA03879J100305/26/2026To elect five (5) director nominees named in the Proxy Statement/Circular, each to serve until the 2027 Annual General and Special Meeting of Shareholders or until his or her qualified successor has been duly elected or appointed: Robert Alan BeardsleyDIRECTOR ELECTIONSISSUER3833797.0000000FOR3833797.000000FORS000002337Arbutus Biopharma Corporation03879J100CA03879J100305/26/2026To elect five (5) director nominees named in the Proxy Statement/Circular, each to serve until the 2027 Annual General and Special Meeting of Shareholders or until his or her qualified successor has been duly elected or appointed: Joseph BishopDIRECTOR ELECTIONSISSUER3833797.0000000FOR3833797.000000FORS000002337Arbutus Biopharma Corporation03879J100CA03879J100305/26/2026To elect five (5) director nominees named in the Proxy Statement/Circular, each to serve until the 2027 Annual General and Special Meeting of Shareholders or until his or her qualified successor has been duly elected or appointed: Matthew GlineDIRECTOR ELECTIONSISSUER3833797.0000000FOR3833797.000000FORS000002337Arbutus Biopharma Corporation03879J100CA03879J100305/26/2026To elect five (5) director nominees named in the Proxy Statement/Circular, each to serve until the 2027 Annual General and Special Meeting of Shareholders or until his or her qualified successor has been duly elected or appointed: Roger Sawhney, MDDIRECTOR ELECTIONSISSUER3833797.0000000FOR3833797.000000FORS000002337Arbutus Biopharma Corporation03879J100CA03879J100305/26/2026To approve the adoption of the Arbutus Biopharma Corporation 2026 Omnibus Share and Incentive Plan;COMPENSATIONISSUER3833797.0000000FOR3833797.000000FORS000002337Arbutus Biopharma Corporation03879J100CA03879J100305/26/2026To approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement/Circular; andSECTION 14A SAY-ON-PAY VOTESISSUER3833797.0000000FOR3833797.000000FORS000002337Arbutus Biopharma Corporation03879J100CA03879J100305/26/2026To approve the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER3833797.0000000FOR3833797.000000FORS000002337ProKidney Corp.74291D104US74291D104605/28/2026Election of Directors: William F. DoyleDIRECTOR ELECTIONSISSUER1119402.0000000FOR1119402.000000FORS000002337ProKidney Corp.74291D104US74291D104605/28/2026Election of Directors: Alan M. Lotvin, M.D.DIRECTOR ELECTIONSISSUER1119402.0000000FOR1119402.000000FORS000002337ProKidney Corp.74291D104US74291D104605/28/2026Election of Directors: Brian J.G. Pereira, M.D.DIRECTOR ELECTIONSISSUER1119402.0000000FOR1119402.000000FORS000002337ProKidney Corp.74291D104US74291D104605/28/2026To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER1119402.0000000FOR1119402.000000FORS000002337Roblox Corporation771049103US771049103305/28/2026Election of Class II Directors: David BaszuckiDIRECTOR ELECTIONSISSUER913686.0000000FOR913686.000000FORS000002337Roblox Corporation771049103US771049103305/28/2026Election of Class II Directors: Gregory BaszuckiDIRECTOR ELECTIONSISSUER913686.0000000FOR913686.000000FORS000002337Roblox Corporation771049103US771049103305/28/2026Election of Class II Directors: Dennis DurkinDIRECTOR ELECTIONSISSUER913686.0000000FOR913686.000000FORS000002337Roblox Corporation771049103US771049103305/28/2026Advisory Vote on the Compensation of our Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER913686.0000000FOR913686.000000FORS000002337Roblox Corporation771049103US771049103305/28/2026Ratification of Independent Registered Public Accounting Firm.AUDIT-RELATEDISSUER913686.0000000FOR913686.000000FORS000002337agilon health, inc.00857U206US00857U206906/02/2026Election of Class II Directors: Diana McKenzieDIRECTOR ELECTIONSISSUER321845.0000000FOR321845.000000FORS000002337agilon health, inc.00857U206US00857U206906/02/2026Election of Class II Directors: Karen McLoughlinDIRECTOR ELECTIONSISSUER321845.0000000FOR321845.000000FORS000002337agilon health, inc.00857U206US00857U206906/02/2026Election of Class II Directors: Ronald WilliamsDIRECTOR ELECTIONSISSUER321845.0000000FOR321845.000000FORS000002337agilon health, inc.00857U206US00857U206906/02/2026Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER321845.0000000FOR321845.000000FORS000002337agilon health, inc.00857U206US00857U206906/02/2026Approval, by advisory vote, of the compensation paid to the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER321845.0000000FOR321845.000000FORS000002337AppLovin Corporation03831W108US03831W108006/03/2026Election of Directors: ADAM FOROUGHIDIRECTOR ELECTIONSISSUER128092.0000000FOR128092.000000FORS000002337AppLovin Corporation03831W108US03831W108006/03/2026Election of Directors: CRAIG BILLINGSDIRECTOR ELECTIONSISSUER128092.0000000FOR128092.000000FORS000002337AppLovin Corporation03831W108US03831W108006/03/2026Election of Directors: HERALD CHENDIRECTOR ELECTIONSISSUER128092.0000000FOR128092.000000FORS000002337AppLovin Corporation03831W108US03831W108006/03/2026Election of Directors: MARGARET GEORGIADISDIRECTOR ELECTIONSISSUER128092.0000000FOR128092.000000FORS000002337AppLovin Corporation03831W108US03831W108006/03/2026Election of Directors: BARBARA MESSINGDIRECTOR ELECTIONSISSUER128092.0000000FOR128092.000000FORS000002337AppLovin Corporation03831W108US03831W108006/03/2026Election of Directors: TODD MORGENFELDDIRECTOR ELECTIONSISSUER128092.0000000FOR128092.000000FORS000002337AppLovin Corporation03831W108US03831W108006/03/2026Election of Directors: VICTORIA VALENZUELADIRECTOR ELECTIONSISSUER128092.0000000FOR128092.000000FORS000002337AppLovin Corporation03831W108US03831W108006/03/2026Election of Directors: EDUARDO VIVASDIRECTOR ELECTIONSISSUER128092.0000000FOR128092.000000FORS000002337AppLovin Corporation03831W108US03831W108006/03/2026Election of Directors: MAYNARD WEBBDIRECTOR ELECTIONSISSUER128092.0000000FOR128092.000000FORS000002337AppLovin Corporation03831W108US03831W108006/03/2026Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER128092.0000000FOR128092.000000FORS000002337AppLovin Corporation03831W108US03831W108006/03/2026Approval, on an advisory basis, of the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER128092.0000000FOR128092.000000FORS000002337AppLovin Corporation03831W108US03831W108006/03/2026Approval of an amendment to our amended and restated certificate of incorporation to provide for officer exculpation as permitted by Delaware law.CORPORATE GOVERNANCEISSUER128092.0000000FOR128092.000000FORS000002337AppLovin Corporation03831W108US03831W108006/03/2026Stockholder proposal regarding disclosure of voting results by class of shares, if properly presented at the meeting.CORPORATE GOVERNANCESECURITY HOLDER128092.0000000FOR128092.000000AGAINSTS000002337Palantir Technologies Inc.69608A108US69608A108806/03/2026Election of Directors: Alexander KarpDIRECTOR ELECTIONSISSUER116843.0000000FOR116843.000000FORS000002337Palantir Technologies Inc.69608A108US69608A108806/03/2026Election of Directors: Stephen CohenDIRECTOR ELECTIONSISSUER116843.0000000FOR116843.000000FORS000002337Palantir Technologies Inc.69608A108US69608A108806/03/2026Election of Directors: Peter ThielDIRECTOR ELECTIONSISSUER116843.0000000FOR116843.000000FORS000002337Palantir Technologies Inc.69608A108US69608A108806/03/2026Election of Directors: Alexander MooreDIRECTOR ELECTIONSISSUER116843.0000000FOR116843.000000FORS000002337Palantir Technologies Inc.69608A108US69608A108806/03/2026Election of Directors: Alexandra SchiffDIRECTOR ELECTIONSISSUER116843.0000000FOR116843.000000FORS000002337Palantir Technologies Inc.69608A108US69608A108806/03/2026Election of Directors: Lauren Friedman StatDIRECTOR ELECTIONSISSUER116843.0000000FOR116843.000000FORS000002337Palantir Technologies Inc.69608A108US69608A108806/03/2026Election of Directors: Eric WoerschingDIRECTOR ELECTIONSISSUER116843.0000000FOR116843.000000FORS000002337Palantir Technologies Inc.69608A108US69608A108806/03/2026Ratification of the appointment of Ernst & Young LLP as Palantir's independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER116843.0000000FOR116843.000000FORS000002337Palantir Technologies Inc.69608A108US69608A108806/03/2026Advisory vote to approve named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER116843.0000000FOR116843.000000FORS000002337Palantir Technologies Inc.69608A108US69608A108806/03/2026Stockholder proposal entitled "Independent Report on Due Diligence Process," if properly presented at the Annual Meeting.HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCESECURITY HOLDER116843.0000000AGAINST116843.000000FORS000002337Palantir Technologies Inc.69608A108US69608A108806/03/2026Stockholder proposal entitled "Human Rights Impact Assessment," if properly presented at the Annual Meeting.HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCESECURITY HOLDER116843.0000000AGAINST116843.000000FORS000002337Palantir Technologies Inc.69608A108US69608A108806/03/2026Stockholder proposal entitled "Political Spending Disclosure," if properly presented at the Annual Meeting.OTHER SOCIAL ISSUESSECURITY HOLDER116843.0000000FOR116843.000000AGAINSTS000002337Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026Election of Directors: Pablo LegorretaDIRECTOR ELECTIONSISSUER1714764.0000000FOR1714764.000000FORS000002337Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026Election of Directors: Ted Love, M.D.DIRECTOR ELECTIONSISSUER1714764.0000000FOR1714764.000000FORS000002337Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026Election of Directors: Bonnie Bassler, Ph.D.DIRECTOR ELECTIONSISSUER1714764.0000000FOR1714764.000000FORS000002337Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026Election of Directors: Vlad Coric, M.D.DIRECTOR ELECTIONSISSUER1714764.0000000FOR1714764.000000FORS000002337Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026Election of Directors: Catherine EngelbertDIRECTOR ELECTIONSISSUER1714764.0000000FOR1714764.000000FORS000002337Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026Election of Directors: Carole Ho, M.D.DIRECTOR ELECTIONSISSUER1714764.0000000FOR1714764.000000FORS000002337Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026Election of Directors: David HodgsonDIRECTOR ELECTIONSISSUER1714764.0000000FOR1714764.000000FORS000002337Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026Election of Directors: Gregory NordenDIRECTOR ELECTIONSISSUER1714764.0000000FOR1714764.000000FORS000002337Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026Election of Directors: Elizabeth WeathermanDIRECTOR ELECTIONSISSUER1714764.0000000FOR1714764.000000FORS000002337Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026A non-binding advisory vote to approve executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1714764.0000000FOR1714764.000000FORS000002337Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm.AUDIT-RELATEDISSUER1714764.0000000FOR1714764.000000FORS000002337Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026Approve receipt of our U.K. audited annual report and accounts and related directors' and auditor's reports for the fiscal year ended December 31, 2025.CORPORATE GOVERNANCEISSUER1714764.0000000FOR1714764.000000FORS000002337Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026Approve on a non-binding advisory basis our U.K. directors' remuneration report for the fiscal year ended December 31, 2025.COMPENSATIONISSUER1714764.0000000FOR1714764.000000FORS000002337Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026Re-appoint Ernst & Young as our U.K. statutory auditor, to hold office until the conclusion of the next general meeting at which the U.K. annual report and accounts are presented to shareholders.AUDIT-RELATEDISSUER1714764.0000000FOR1714764.000000FORS000002337Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026Authorize the Board to determine the remuneration of Ernst & Young in its capacity as our U.K. statutory auditor.AUDIT-RELATEDISSUER1714764.0000000FOR1714764.000000FORS000002337Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026Approve the terms of the agreements and counterparties pursuant to which we may purchase our Class A ordinary shares.CAPITAL STRUCTUREISSUER1714764.0000000FOR1714764.000000FORS000002337Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026Authorize the Board to allot shares.CAPITAL STRUCTUREISSUER1714764.0000000FOR1714764.000000FORS000002337Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026Authorize the Board to allot shares without rights of pre-emption (special resolution).CAPITAL STRUCTUREISSUER1714764.0000000FOR1714764.000000FORS000002337Strategy Inc594972408US594972408306/08/2026To elect the following eight (8) directors for the next year: Michael J. SaylorDIRECTOR ELECTIONSISSUER225226.0000000FOR225226.000000FORS000002337Strategy Inc594972408US594972408306/08/2026To elect the following eight (8) directors for the next year: Phong Q. LeDIRECTOR ELECTIONSISSUER225226.0000000FOR225226.000000FORS000002337Strategy Inc594972408US594972408306/08/2026To elect the following eight (8) directors for the next year: Brian P. BrooksDIRECTOR ELECTIONSISSUER225226.0000000FOR225226.000000FORS000002337Strategy Inc594972408US594972408306/08/2026To elect the following eight (8) directors for the next year: Jane A. DietzeDIRECTOR ELECTIONSISSUER225226.0000000FOR225226.000000FORS000002337Strategy Inc594972408US594972408306/08/2026To elect the following eight (8) directors for the next year: Stephen X. GrahamDIRECTOR ELECTIONSISSUER225226.0000000FOR225226.000000FORS000002337Strategy Inc594972408US594972408306/08/2026To elect the following eight (8) directors for the next year: Jarrod M. PattenDIRECTOR ELECTIONSISSUER225226.0000000FOR225226.000000FORS000002337Strategy Inc594972408US594972408306/08/2026To elect the following eight (8) directors for the next year: Carl J. RickertsenDIRECTOR ELECTIONSISSUER225226.0000000FOR225226.000000FORS000002337Strategy Inc594972408US594972408306/08/2026To elect the following eight (8) directors for the next year: Gregg J. WiniarskiDIRECTOR ELECTIONSISSUER225226.0000000FOR225226.000000FORS000002337Strategy Inc594972408US594972408306/08/2026To ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER225226.0000000FOR225226.000000FORS000002337Strategy Inc594972408US594972408306/08/2026To approve, on an advisory, non-binding basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER225226.0000000FOR225226.000000FORS000002337Strategy Inc594972408US594972408306/08/2026To ratify, pursuant to Section 204 of the General Corporation Law of the State of Delaware, the filing and effectiveness of the Certificate of Amendment to the Certificate of Designations of the Company's 8.00% Series A Perpetual Strike Preferred Stock filed with the Secretary of State of the State of Delaware on July 7, 2025, and the amendment to the liquidation preference of such stock effectuated thereby.CAPITAL STRUCTUREISSUER225226.0000000FOR225226.000000FORS000002337Strategy Inc594972408US594972408306/08/2026To approve and adopt an amendment and restatement of the Certificate of Designations of the Company's Variable Rate Series A Perpetual Stretch Preferred Stock to provide for two scheduled dividend payment dates per month, instead of one.CAPITAL STRUCTUREISSUER225226.0000000FOR225226.000000FORS000002337MercadoLibre, Inc.58733R102US58733R102306/09/2026Election of Directors: Class I Nominees: Susan SegalDIRECTOR ELECTIONSISSUER9233.0000000FOR9233.000000FORS000002337MercadoLibre, Inc.58733R102US58733R102306/09/2026Election of Directors: Class I Nominees: Stelleo Passos ToldaDIRECTOR ELECTIONSISSUER9233.0000000FOR9233.000000FORS000002337MercadoLibre, Inc.58733R102US58733R102306/09/2026Election of Directors: Class I Nominees: Alejandro Nicolas AguzinDIRECTOR ELECTIONSISSUER9233.0000000FOR9233.000000FORS000002337MercadoLibre, Inc.58733R102US58733R102306/09/2026To approve, on an advisory basis, the compensation of our named executive officers for fiscal year 2025.SECTION 14A SAY-ON-PAY VOTESISSUER9233.0000000FOR9233.000000FORS000002337MercadoLibre, Inc.58733R102US58733R102306/09/2026To ratify the appointment of Pistrelli, Henry Martin y Asociados S.A., a member firm of Ernst & Young Global Limited, as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER9233.0000000FOR9233.000000FORS000002337Opendoor Technologies Inc.683712103US683712103606/11/2026To elect three nominees to hold office as Class III members of our Board of Directors until the 2029 Annual Meeting of Stockholders: David BensonDIRECTOR ELECTIONSISSUER12569205.0000000FOR12569205.000000FORS000002337Opendoor Technologies Inc.683712103US683712103606/11/2026To elect three nominees to hold office as Class III members of our Board of Directors until the 2029 Annual Meeting of Stockholders: Eric FederDIRECTOR ELECTIONSISSUER12569205.0000000FOR12569205.000000FORS000002337Opendoor Technologies Inc.683712103US683712103606/11/2026To elect three nominees to hold office as Class III members of our Board of Directors until the 2029 Annual Meeting of Stockholders: Eric WuDIRECTOR ELECTIONSISSUER12569205.0000000FOR12569205.000000FORS000002337Opendoor Technologies Inc.683712103US683712103606/11/2026To ratify the appointment by the Audit and Risk Committee of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER12569205.0000000FOR12569205.000000FORS000002337Opendoor Technologies Inc.683712103US683712103606/11/2026To approve, on an advisory (non-binding) basis, the compensation of our named executive officers (Say-on-Pay Vote).SECTION 14A SAY-ON-PAY VOTESISSUER12569205.0000000FOR12569205.000000FORS000002337IonQ, Inc.46222L108US46222L108906/16/2026To elect two Class II directors to hold office until our 2029 Annual Meeting of Stockholders and until a successor is duly elected and qualified or until earlier resignation or removal: Kathryn K. ChouDIRECTOR ELECTIONSISSUER0.0000001383642.000000S000002337IonQ, Inc.46222L108US46222L108906/16/2026To elect two Class II directors to hold office until our 2029 Annual Meeting of Stockholders and until a successor is duly elected and qualified or until earlier resignation or removal: William F. ScannellDIRECTOR ELECTIONSISSUER0.0000001383642.000000S000002337IonQ, Inc.46222L108US46222L108906/16/2026To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER0.0000001383642.000000S000002337IonQ, Inc.46222L108US46222L108906/16/2026To approve, on an advisory basis, the compensation of our named executive officers in 2025.SECTION 14A SAY-ON-PAY VOTESISSUER0.0000001383642.000000S000002337Shopify Inc.82509L107CA82509L107606/16/2026Elect Director Tobias LutkeDIRECTOR ELECTIONSISSUER386659.0000000FOR386659.000000FORS000002337Shopify Inc.82509L107CA82509L107606/16/2026Elect Director Joseph (Joe) NataleDIRECTOR ELECTIONSISSUER386659.0000000FOR386659.000000FORS000002337Shopify Inc.82509L107CA82509L107606/16/2026Elect Director Lulu Cheng MeserveyDIRECTOR ELECTIONSISSUER386659.0000000FOR386659.000000FORS000002337Shopify Inc.82509L107CA82509L107606/16/2026Elect Director Jeanne DeWitt GrosserDIRECTOR ELECTIONSISSUER386659.0000000FOR386659.000000FORS000002337Shopify Inc.82509L107CA82509L107606/16/2026Elect Director David Heinemeier HanssonDIRECTOR ELECTIONSISSUER386659.0000000FOR386659.000000FORS000002337Shopify Inc.82509L107CA82509L107606/16/2026Elect Director Jeremy LevineDIRECTOR ELECTIONSISSUER386659.0000000FOR386659.000000FORS000002337Shopify Inc.82509L107CA82509L107606/16/2026Elect Director Prashanth Mahendra-RajahDIRECTOR ELECTIONSISSUER386659.0000000FOR386659.000000FORS000002337Shopify Inc.82509L107CA82509L107606/16/2026Elect Director Kevin ScottDIRECTOR ELECTIONSISSUER386659.0000000FOR386659.000000FORS000002337Shopify Inc.82509L107CA82509L107606/16/2026Elect Director Toby ShannanDIRECTOR ELECTIONSISSUER386659.0000000FOR386659.000000FORS000002337Shopify Inc.82509L107CA82509L107606/16/2026Elect Director Fidji SimoDIRECTOR ELECTIONSISSUER386659.0000000FOR386659.000000FORS000002337Shopify Inc.82509L107CA82509L107606/16/2026Approve PricewaterhouseCoopers LLP as Auditors and Authorize Board to Fix Their RemunerationAUDIT-RELATEDISSUER386659.0000000FOR386659.000000FORS000002337Shopify Inc.82509L107CA82509L107606/16/2026Advisory Vote on Executive Compensation ApproachCOMPENSATIONISSUER386659.0000000FOR386659.000000FORS000002337Shopify Inc.82509L107CA82509L107606/16/2026Adopt a Policy on Responsible Use of Artificial Intelligence ("AI") in the Company's Business and OperationsOTHER SOCIAL ISSUESSECURITY HOLDER386659.0000000AGAINST386659.000000FORS000002337QXO, Inc.82846H405US82846H405606/29/2026QXO Share Issuance Proposal. To vote on a proposal to approve the issuance of shares of common stock, par value $0.00001 per share, of QXO (the "QXO shares"), constituting the stock consideration to be issued to stockholders of TopBuild Corp., a Delaware corporation ("TopBuild"), in the Titanium Merger as defined and contemplated by the Agreement and Plan of Merger, dated as of April 18, 2026, by and among QXO, Titanium MergerCo, Inc., a Delaware corporation and wholly owned subsidiary of QXO ("Titanium Merger Sub"), Titanium MergerCo 2, LLC, a Delaware limited liability company and wholly owned subsidiary of QXO ("Forward Merger Sub"), and TopBuild (as that agreement may be amended from time to time, the "merger agreement"), a copy of which is included as Annex A to the accompanying joint proxy statement/prospectus, and other QXO shares to be issued in the mergers or reserved for issuance in connection with the mergers (the "QXO share issuance proposal").EXTRAORDINARY TRANSACTIONSISSUER3190768.0000000FOR3190768.000000FORS000002337QXO, Inc.82846H405US82846H405606/29/2026QXO Charter Amendment Proposal. To vote on a proposal to approve an amendment of QXO's certificate of incorporation to increase the number of authorized QXO shares from 2,000,000,000 to 4,000,000,000, in the form attached to the accompanying joint proxy statement/prospectus as Annex E (the "QXO charter amendment proposal").CAPITAL STRUCTUREISSUER3190768.0000000FOR3190768.000000FORS000002337QXO, Inc.82846H405US82846H405606/29/2026Adjournment Proposal. To vote on a proposal to adjourn the QXO stockholder meeting, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes to approve the QXO share issuance proposal at the time of the QXO stockholder meeting (the "QXO adjournment proposal").CORPORATE GOVERNANCEISSUER3190768.0000000FOR3190768.000000FORS000002337Cloudflare, Inc.18915M107US18915M107106/30/2026Election of Class I directors: Michelle ZatlynDIRECTOR ELECTIONSISSUER663574.0000000FOR663574.000000FORS000002337Cloudflare, Inc.18915M107US18915M107106/30/2026Election of Class I directors: Scott SandellDIRECTOR ELECTIONSISSUER663574.0000000FOR663574.000000FORS000002337Cloudflare, Inc.18915M107US18915M107106/30/2026Election of Class I directors: Karim LakhaniDIRECTOR ELECTIONSISSUER663574.0000000FOR663574.000000FORS000002337Cloudflare, Inc.18915M107US18915M107106/30/2026Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER663574.0000000FOR663574.000000FORS000002337Cloudflare, Inc.18915M107US18915M107106/30/2026Approval, on an advisory basis, of the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER663574.0000000FOR663574.000000FORS000002337Cloudflare, Inc.18915M107US18915M107106/30/2026Approval and adoption of an amendment and restatement of our amended and restated certificate of incorporation: Approval and adoption of amendments to establish the Class C common stock.CAPITAL STRUCTUREISSUER663574.0000000FOR663574.000000FORS000002337Cloudflare, Inc.18915M107US18915M107106/30/2026Approval and adoption of amendments to increase the number of authorized shares of Class A common stock from 2,250,000,000 to 4,500,000,000.CAPITAL STRUCTUREISSUER663574.0000000FOR663574.000000FORS000002337Cloudflare, Inc.18915M107US18915M107106/30/2026Approval and adoption of amendments to increase the number of authorized shares of preferred stock from 225,000,000 to 450,000,000.CAPITAL STRUCTUREISSUER663574.0000000FOR663574.000000FORS000002337Cloudflare, Inc.18915M107US18915M107106/30/2026Approval and adoption of amendments to implement a stock split in which (i) each share of Class A common stock would become one share of Class A common stock and one share of Class C common stock; and (ii) each share of Class B common stock would become one share of Class B common stock and one share of Class C common stock.CAPITAL STRUCTUREISSUER663574.0000000FOR663574.000000FORS000002337Cloudflare, Inc.18915M107US18915M107106/30/2026Approval and adoption of amendments to provide for the equal treatment of shares of Class A common stock, Class B common stock, and Class C common stock in connection with dividends and distributions, certain transactions, and upon our liquidation, dissolution, or winding up.CAPITAL STRUCTUREISSUER663574.0000000FOR663574.000000FORS000002337Cloudflare, Inc.18915M107US18915M107106/30/2026Approval and adoption of amendments to require the approval of a majority of the independent directors then in office for any acquisition in which we would issue shares of Class C common stock as consideration for such acquisition with a fair market value in excess of $100,000,000.CORPORATE GOVERNANCEISSUER663574.0000000FOR663574.000000FORS000002337Cloudflare, Inc.18915M107US18915M107106/30/2026Approval of the amendment and restatement of our 2019 Equity Incentive Plan.COMPENSATIONISSUER663574.0000000FOR663574.000000FORS000002337Cloudflare, Inc.18915M107US18915M107106/30/2026Approval of the amendment and restatement of our Amended and Restated 2019 Employee Stock Purchase Plan.COMPENSATIONISSUER663574.0000000FOR663574.000000FORS000002337Cloudflare, Inc.18915M107US18915M107106/30/2026Approval of one or more adjournments of the meeting, if necessary to solicit additional proxies in favor of the proposals presented at the meeting.CORPORATE GOVERNANCEISSUER663574.0000000FOR663574.000000FORS000002337